STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

Kalshi, a major prediction market exchange, will launch markets for betting on clinical trials and FDA approvals in collaboration with tech partner AppliedXL. The initiative expands prediction markets into the biopharma industry, focusing on clinical trial outcomes and regulatory decisions.